Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
SARS-CoV2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Home
Publications
SARS-CoV2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
SARS-CoV2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
4 July 2021
component
Published by
American Chemical Society (ACS)
DOI:
10.1021/acschembio.1c00272.s001
Abstract
No abstract available
Cited
Cited by 1 article
Scroll to top